These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 2166191)

  • 1. Physiologic assessment of Isshiki type III thyroplasty.
    Slavit DH; Maragos NE; Lipton RJ
    Laryngoscope; 1990 Aug; 100(8):844-8. PubMed ID: 2166191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Longitudinal voice quality changes following Isshiki thyroplasty type I: the Yale experience.
    Sasaki CT; Leder SB; Petcu L; Friedman CD
    Laryngoscope; 1990 Aug; 100(8):849-52. PubMed ID: 2166192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surgical alteration of the vocal pitch.
    Isshiki N; Taira T; Tanabe M
    J Otolaryngol; 1983 Oct; 12(5):335-40. PubMed ID: 6644864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thyroplasty type I with Montgomery implant among native French language speakers with unilateral laryngeal nerve paralysis.
    Laccourreye O; El Sharkawy L; Holsinger FC; Hans S; Ménard M; Brasnu D
    Laryngoscope; 2005 Aug; 115(8):1411-7. PubMed ID: 16094114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Arytenoid adduction and type I thyroplasty in the treatment of aphonia.
    Slavit DH; Maragos NE
    J Voice; 1994 Mar; 8(1):84-91. PubMed ID: 8167793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term results of type II thyroplasty for adductor spasmodic dysphonia.
    Chan SW; Baxter M; Oates J; Yorston A
    Laryngoscope; 2004 Sep; 114(9):1604-8. PubMed ID: 15475790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short-term results of laryngeal framework surgery--thyroplasty type 1: A pilot study.
    Harries ML; Morrison M
    J Otolaryngol; 1995 Oct; 24(5):281-7. PubMed ID: 8537986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Assessment of thyroplasty for vocal fold paralysis].
    Grøntved AM; Faber CE; Jakobsen J
    Ugeskr Laeger; 2009 Jan; 171(3):117-21. PubMed ID: 19174018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medialization thyroplasty with a customized silicone implant: clinical experience.
    Chrobok V; Pellant A; Sram F; Fric M; Praisler J; Prymula R; Svec JG
    Folia Phoniatr Logop; 2008; 60(2):91-6. PubMed ID: 18235197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relaxation thyroplasty for mutational falsetto treatment.
    Remacle M; Matar N; Verduyckt I; Lawson G
    Ann Otol Rhinol Laryngol; 2010 Feb; 119(2):105-9. PubMed ID: 20336921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Montgomery thyroplasty implant under local anesthesia for unilateral laryngeal paralysis].
    Michel F; Hans S; Crevier-Buchman L; Brasnu D; Menard M; Laccourreye O
    Ann Otolaryngol Chir Cervicofac; 2003 Nov; 120(5):259-67. PubMed ID: 14726844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Laryngeal framework surgery for voice improvement.
    Mahieu HF; Norbart T; Snel F
    Rev Laryngol Otol Rhinol (Bord); 1996; 117(3):189-97. PubMed ID: 9102725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acoustic evaluation of Isshiki type III thyroplasty for treatment of mutational voice disorders.
    Li GD; Mu L; Yang S
    J Laryngol Otol; 1999 Jan; 113(1):31-4. PubMed ID: 10341916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increasing the closed quotient improves voice quality after type I thyroplasty in patients with unilateral vocal cord paralysis: analysis using SPEAD program.
    Choi HS; Chung SM; Lim JY; Kim HS
    J Voice; 2008 Nov; 22(6):751-5. PubMed ID: 17624724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thyroplasty for adductor spasmodic dysphonia: further experiences.
    Isshiki N; Haji T; Yamamoto Y; Mahieu HF
    Laryngoscope; 2001 Apr; 111(4 Pt 1):615-21. PubMed ID: 11359129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Type III thyroplasty for the treatment of glottic gap in a patient undergoing laryngofissure cordectomy for squamous cell carcinoma of the vocal fold: technique and outcome.
    Kandogan T
    Ear Nose Throat J; 2010 Jun; 89(6):272-5. PubMed ID: 20556739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of type II thyroplasty on adductor spasmodic dysphonia.
    Sanuki T; Yumoto E; Minoda R; Kodama N
    Otolaryngol Head Neck Surg; 2010 Apr; 142(4):540-6. PubMed ID: 20304275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The study of vocal fold vibratory patterns in patients with unilateral vocal fold paralysis before and after type I thyroplasty with or without arytenoid adduction.
    Thompson DM; Maragos NE; Edwards BW
    Laryngoscope; 1995 May; 105(5 Pt 1):481-6. PubMed ID: 7760662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progress in laryngeal framework surgery.
    Isshiki N
    Acta Otolaryngol; 2000 Mar; 120(2):120-7. PubMed ID: 11603755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent modifications in thyroplasty type I.
    Isshiki N; Taira T; Kojima H; Shoji K
    Ann Otol Rhinol Laryngol; 1989 Oct; 98(10):777-9. PubMed ID: 2802460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.